Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers

Updated version: Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers - 2009 Volume 35 Supplement -1 - June 2009

Supplement

June 2004 Volume 30S1
PDF Version (142 KB)

Contained in this issue:

Table of Contents

Preface

1. Introduction
2. Prevention
   1. Risk of Acquiring Malaria
   2. Personal Protective Measures to Prevent Mosquito Bites
   3. Chemoprophylactic Drugs (where appropriate)
   4. Early Diagnosis and Treatment
3. Chemoprophylactic Regimens
   1. Introduction
   2. Chloroquine-sensitive Regions
   3. Chloroquine-resistant Regions
   4. Chloroquine- and Mefloquine-resistant Regions
   5. Primaquine Terminal Prophylaxis for Prevention of Relapses of
      P. vivax and P. ovale
   6. Selection of Antimalarial Drugs for Individual Travellers
4. Prevention of Malaria in Special Hosts
   1. Malaria Prevention in Children
   2. Malaria Prevention in Pregnancy
   3. Prophylaxis While Breast-Feeding
   4. Malaria Prevention in the Medically Compromised Host
5. Malaria Prevention in the Long-term Traveller or Expatriate
6. Self-treatment of Presumptive Malaria
   Step 1. Discuss Common Errors Concerning Malaria Recognition and Management
   Step 2. Advise that Malaria Presents in Various ways
   Step 3. Indicate the Need to Seek Professional Medical Care As Soon As Possible
   Step 4. Select the Self-treatment Drug with Care
   Step 5. Educate About Drugs to Avoid
7. Malaria Diagnosis
8. Treatment of Malaria
   1. General Principles of Management
   2. Management of Falciparum Malaria
   3. Management of Non-falciparum Malaria
9. Drugs for the Prevention and Treatment of Malaria

Appendix I. Malaria Risk by Geographic Area in Countries with Endemic Malaria
Appendix II. Strength and Quality of Evidence Summary
Appendix III. Instructions for Insecticide Treatment of Bed Nets and Clothing
Appendix IV. Checklist for Travellers to Malarial Areas
Appendix V. Frequently Asked Questions about Malaria
Appendix VI. Contact Information for the Canadian Malaria Network

Preface

The prevention and treatment of malaria have changed considerably over the last decade, primarily as a result of the development and spread of drug-resistant parasites and a global resurgence of disease.

The following recommendations are guidelines prepared by the Malaria Subcommittee of CATMAT for health care providers to assist travellers in preventing symptomatic malaria and reducing the risk of severe illness or death from this infection.

The Travel Medicine Program at Health Canada provides a valuable resource for the traveller and the travel medicine provider. Information concerning malaria and many aspects of the health of travelling Canadians is available at www.travelhealth.gc.ca.

CATMAT Members
Dr. B. Ward (Chairman); H. Birk; M. Bodie-Collins (Executive Secretary); Dr. H.O. Davies; Dr. M-H Favreau; Dr. K. Gamble; Dr. S. Kuhn; Dr. A. McCarthy; Dr. P.J. Plourde; Dr. J.R. Salzman

Liaison Representatives
Dr. R. Birnbaum (CSIH); L. Cobb (CUSO); Dr. V. Marchessault (CPS and NACI); Dr. H. Onyette (CIDS); Dr. R. Saginur (CPHA)

Ex-Officio Representatives
Dr. E. Callary (HC); R. Dewart (CDC); Dr. E. Gadd (TPD); Dr. N. Gibson (DND); Dr. M. Lapointe (CIC); Dr. V. Lentini (DND); Dr. M. Parise (CDC)

Member Emeritus
Dr. C.W.L. Jeanes

Malaria Subcommittee Members
Dr. A.E. McCarthy (Chair); Dr. K. Gamble; Dr. S. Kuhn; Dr. P.J. Plourde; Dr. P. McDonald; Dr. M. Parise; Dr. N. Gibson; Dr. K. McLean; Dr. C. Greenaway; Dr. M. Tepper